Crucell sales and marketing update

CRXL co-developed Quinvaxem with Chiron, which is now part of Novartis AG (NVS; SWX:NOVN, Basel, Switzerland). The company got Hepavax-Gene through its acquisition of Berna Biotech Ltd. earlier this...